Aditxt (ADTX) Asset Utilization Ratio (2022 - 2026)

Aditxt (ADTX) recorded quarterly Asset Utilization Ratio of 0.0 in Q1 2026, up 317.62% quarter-over-quarter from 0.0 in Q4 2025, and down 46.03% on a YoY basis from 0.0 in Q1 2025.

Aditxt (ADTX) Asset Utilization Ratio (2022 - 2026) Analysis & Trends

Aditxt's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 46.03% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 46.03% YoY), while the FY2025 annual figure was 0.0, down 96.24% from the prior year.
  • Asset Utilization Ratio was 0.0 for Q1 2026 at Aditxt, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.13 in Q2 2023 to a low of 0.0 in Q4 2025.
  • Historically, Asset Utilization Ratio has averaged 0.03 across 5 years, with a median of 0.01 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio plunged 96.78% in 2025, then slumped 46.03% in 2026.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2022, then slumped by 60.85% to 0.02 in 2023, then sank by 82.31% to 0.0 in 2024, then plunged by 94.78% to 0.0 in 2025, then surged by 317.62% to 0.0 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.10
Jun 30, 2023 0.13
Mar 31, 2023 0.10
Dec 31, 2022 0.06